Company intelligence / Profile preview
Wuhan Houxian Biomedical
- Ownership
- Private
- Development stage
- Other
Overview
Wuhan Houxian Biomedical is a biotechnology company focused on the development of mRNA-based vaccines and therapeutics. The company utilizes a proprietary lipid nanoparticle (LNP) delivery system and mRNA sequence optimization technology to address infectious diseases and oncology. Located in the Wuhan East Lake High-tech Development Zone (Optics Valley), it aims to establish a vertically integrated platform for mRNA drug discovery and production. Their current research focus includes vaccines for respiratory viruses such as COVID-19 and RSV, as well as innovative cancer treatments. The firm is led by experts in nucleic acid medicine and delivery systems.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapyVaccine
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Wuhan Houxian Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan Houxian Biomedical.